ANTIPODES PARTNERS Ltd Sells 435,646 Shares of Ventas, Inc. $VTR

ANTIPODES PARTNERS Ltd lowered its stake in Ventas, Inc. (NYSE:VTR) by 28.4% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 1,100,395 shares of the real estate investment trust’s stock after selling 435,646 shares during the period. Ventas makes up 1.7% of ANTIPODES PARTNERS Ltd’s portfolio, making the stock its 26th largest holding. ANTIPODES PARTNERS Ltd owned 0.23% of Ventas worth $77,022,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in VTR. Cloud Capital Management LLC acquired a new position in Ventas in the 3rd quarter valued at $25,000. True Wealth Design LLC lifted its holdings in shares of Ventas by 1,557.7% during the third quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock worth $30,000 after buying an additional 405 shares in the last quarter. ORG Partners LLC boosted its position in shares of Ventas by 76.1% in the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock valued at $32,000 after acquiring an additional 197 shares during the period. Wilmington Savings Fund Society FSB grew its stake in shares of Ventas by 65.5% in the third quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock valued at $32,000 after acquiring an additional 180 shares in the last quarter. Finally, Golden State Wealth Management LLC increased its position in Ventas by 52.7% during the second quarter. Golden State Wealth Management LLC now owns 536 shares of the real estate investment trust’s stock worth $34,000 after acquiring an additional 185 shares during the period. 94.18% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the stock. Morgan Stanley set a $90.00 price objective on shares of Ventas in a report on Friday, February 13th. Jefferies Financial Group reiterated a “buy” rating and issued a $93.00 price target on shares of Ventas in a research report on Monday, December 15th. Citigroup increased their price target on Ventas from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Wednesday, February 11th. Wells Fargo & Company increased their price objective on shares of Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Finally, The Goldman Sachs Group restated a “buy” rating and issued a $100.00 target price on shares of Ventas in a research report on Monday, February 9th. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Ventas presently has a consensus rating of “Moderate Buy” and a consensus price target of $86.87.

Insider Buying and Selling at Ventas

In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of the company’s stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total transaction of $801,606.52. Following the sale, the chief executive officer owned 1,114,034 shares of the company’s stock, valued at approximately $86,515,880.44. This represents a 0.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Robert F. Probst sold 29,930 shares of Ventas stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $77.25, for a total value of $2,312,092.50. Following the completion of the transaction, the chief financial officer directly owned 138,434 shares of the company’s stock, valued at approximately $10,694,026.50. This trade represents a 17.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 86,106 shares of company stock valued at $6,931,397. 0.80% of the stock is currently owned by insiders.

Ventas Trading Up 0.5%

Shares of NYSE VTR opened at $85.87 on Friday. The stock has a market cap of $40.78 billion, a P/E ratio of 159.01, a price-to-earnings-growth ratio of 2.09 and a beta of 0.77. The firm has a 50 day moving average price of $79.25 and a two-hundred day moving average price of $74.46. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67. Ventas, Inc. has a 52-week low of $60.15 and a 52-week high of $87.24.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The company had revenue of ($1,229.71) million during the quarter, compared to analyst estimates of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. The business’s revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.81 earnings per share. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, equities analysts forecast that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be paid a $0.52 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. This is an increase from Ventas’s previous quarterly dividend of $0.48. Ventas’s payout ratio is currently 355.56%.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.